What is CEMTREX INC SRS 1 PFD's earnings per share (EPS)?

CEMTREX INC SRS 1 PFD (CETXP) reported diluted earnings per share of -$210.88 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CEMTREX INC SRS 1 PFD (CETXP) Financials

CETXP

Trailing 12 months to June 30, 2026

Revenue $71.2M -6.5% YoY

Net Income -$27.5M -35.3% YoY

EPS (Diluted) -$210.88 FY2025 annual

Free Cash Flow -$9.6M -1155.3% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Aug 14, 2026 Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CETXP SEC filings page.

CEMTREX INC SRS 1 PFD (CETXP) reported $71.2M in revenue over the twelve months to Jun 30, 2026, down 6.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CETXP FY2025 2026-08-30

Cemtrex’s operating model is reaching break-even as revenue expands, while below-operating charges still reshape earnings.

The key split in FY2025 is between operating income of $510K and net loss of -$28.1M: core operations reached roughly break-even, but reported earnings were determined largely below that line. That contrasts with FY2024, when operating income was -$5.3M and net loss was -$7.2M, showing that operating improvement has not reliably flowed through to net earnings.

Gross margin moved from 36.8% in FY2022 to 42.2% in FY2025, indicating better gross economics as the business expanded. FY2025 gross profit was $32.3M against SG&A of $28.2M, leaving little room for other operating costs; the result was only a 0.7% operating margin.

Debt-to-equity fell from 2.8x in FY2024 to 0.5x in FY2025, indicating materially less debt relative to reported equity. Total liabilities remained $39.1M, while a 1.2x current ratio shows short-term coverage is positive but not roomy.

Financial Health Signals

Financial health score not available

CEMTREX INC SRS 1 PFD does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Neutral

5/9

CEMTREX INC SRS 1 PFD passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

N/A

CEMTREX INC SRS 1 PFD reported a net loss of $28.1M while generating $159K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

0.24x

CEMTREX INC SRS 1 PFD earns $0.24 in operating income for every $1 of interest expense ($510K vs $2.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$18.4M

YoY+8.7%

QoQ+2.1%

5Y CAGR+12.3%

CEMTREX INC SRS 1 PFD generated $18.4M in revenue in Q3 2026. This represents an increase of 8.7% from the same quarter a year earlier. Against the prior quarter it is up 2.1%.

EBITDA

-$611K

YoY-85.6%

QoQ+63.1%

CEMTREX INC SRS 1 PFD's EBITDA was -$611K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 85.6% from the same quarter a year earlier. Against the prior quarter it is up 63.1%.

Net Income

-$4.5M

YoY+3.3%

QoQ-593.9%

CEMTREX INC SRS 1 PFD reported -$4.5M in net income in Q3 2026. This represents an increase of 3.3% from the same quarter a year earlier. Against the prior quarter it is down 593.9%.

EPS (Diluted)

-$3.27

CEMTREX INC SRS 1 PFD earned -$3.27 per diluted share (EPS) in Q3 2026.

Cash & Balance Sheet

Free Cash Flow

-$220K

YoY-112.7%

QoQ+95.2%

CEMTREX INC SRS 1 PFD recorded an outflow of $220K in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents a decrease of 112.7% from the same quarter a year earlier. Against the prior quarter it is up 95.2%.

Cash & Debt

$8.0M

YoY+13.4%

QoQ+21.4%

5Y CAGR-9.1%

10Y CAGR+12.9%

CEMTREX INC SRS 1 PFD held $8.0M in cash against $8.6M in long-term debt as of Q3 2026.

Shares Outstanding

5Y CAGR-39.2%

CEMTREX INC SRS 1 PFD had 2M shares outstanding in Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

41.7%

YoY-1.7pp

QoQ+3.8pp

5Y change+1.8pp

CEMTREX INC SRS 1 PFD's gross margin was 41.7% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.

Operating Margin

-6.5%

YoY-2.7pp

QoQ+5.6pp

5Y change+15.8pp

CEMTREX INC SRS 1 PFD's operating margin was -6.5% in Q3 2026, reflecting core business profitability. This is down 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.6 percentage points.

Net Margin

-24.3%

YoY+3.0pp

QoQ-29.3pp

5Y change-34.9pp

CEMTREX INC SRS 1 PFD's net profit margin was -24.3% in Q3 2026, showing the share of revenue converted to profit. This is up 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 29.3 percentage points.

Return on Equity

-14.0%

YoY+106.3pp

QoQ-16.6pp

CEMTREX INC SRS 1 PFD's ROE was -14.0% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 106.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 16.6 percentage points.

Capital Allocation

R&D Spending

$425K

YoY+10.0%

QoQ-22.2%

5Y CAGR-10.9%

CEMTREX INC SRS 1 PFD invested $425K in research and development in Q3 2026. This represents an increase of 10.0% from the same quarter a year earlier. Against the prior quarter it is down 22.2%.

Capital Expenditures

$630K

YoY+731.4%

QoQ+311.2%

5Y CAGR+30.1%

CEMTREX INC SRS 1 PFD invested $630K in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 731.4% from the same quarter a year earlier. Against the prior quarter it is up 311.2%.

Share Buybacks

Not reported for Q3 2026.

CETXP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CETXP quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$71.2M	$76.5M+14.4%	$66.9M+12.6%	$59.4M+31.9%	$45.0M+4.4%	$43.1M-0.9%	$43.5M+10.8%	$39.3M+73.4%	$22.6M-81.2%	$120.6M+28.7%	$93.7M+64.7%	$56.9M+19.4%	$47.7M+248.5%	$13.7M+12.4%	$12.2M-11.4%	$13.7M
Cost of Revenue	$44.0M	$44.2M+12.2%	$39.4M+16.9%	$33.7M+18.3%	$28.5M+8.8%	$26.2M+1.0%	$25.9M+9.3%	$23.7M+64.3%	$14.4M-64.0%	$40.1M+13.0%	$35.5M+42.9%	$24.8M-22.5%	$32.1M+155.9%	$12.5M+16.2%	$10.8M-7.0%	$11.6M
Gross Profit	$27.2M	$32.3M+17.5%	$27.5M+7.0%	$25.7M+55.1%	$16.6M-2.4%	$17.0M-3.7%	$17.6M+13.2%	$15.6M+89.4%	$8.2M-79.4%	$39.9M+36.6%	$29.2M+79.0%	$16.3M+4.7%	$15.6M+1262.1%	$1.1M-16.8%	$1.4M-35.4%	$2.1M
R&D Expenses	$1.8M	$2.4M-29.9%	$3.4M+2.7%	$3.3M-26.5%	$4.4M+40.1%	$3.2M+73.6%	$1.8M+23.3%	$1.5M-73.3%	$5.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$31.1M	$28.2M+2.2%	$27.6M+20.4%	$22.9M+8.1%	$21.2M-6.0%	$22.5M+10.7%	$20.4M-5.4%	$21.5M+41.6%	$15.2M-56.3%	$34.8M+44.1%	$24.1M+74.7%	$13.8M+9.9%	$12.6M+1476.4%	$798K+16.8%	$683K-33.5%	$1.0M
Operating Income	-$7.4M	$510K+109.7%	-$5.3M-248.6%	-$1.5M+89.3%	-$14.1M-61.6%	-$8.7M-91.3%	-$4.6M+38.6%	-$7.4M+40.7%	-$12.6M-345.3%	$5.1M+1.0%	$5.1M+102.5%	$2.5M-17.0%	$3.0M+768.7%	$347K-49.9%	$693K-37.3%	$1.1M
EBITDA	N/A	$1.9M+147.3%	-$3.9M-711.9%	-$485K+96.1%	-$12.4M-67.1%	-$7.4M-173.9%	-$2.7M+39.0%	-$4.4M+56.7%	-$10.2M-223.9%	$8.3M+12.2%	$7.4M+124.8%	$3.3M-6.7%	$3.5M+879.9%	$358K-49.7%	$712K-36.9%	$1.1M
Interest Expense	$13.9M	$2.1M-2.7%	$2.2M-56.3%	$5.0M+28.0%	$3.9M+32.8%	$2.9M-36.6%	$4.6M-3.7%	$4.8M+497.9%	$800K-13.4%	$924K+37.2%	$674K+35.7%	$496K+13.6%	$437K+852.8%	$46K+9.0%	$42K+145.2%	-$93K
Income Tax	$711K	$735K+263.3%	$202K-48.7%	$394K+288.3%	-$209K-155.8%	$375K-81.9%	$2.1M+255.3%	-$1.3M+53.3%	-$2.9M-2374.5%	-$116K-110.6%	$1.1M+118784.6%	$917-98.5%	$61K+387.7%	$13K+403.6%	$2K	$0
Net Income	-$27.5M	-$28.1M-288.9%	-$7.2M-378.3%	-$1.5M+88.4%	-$13.0M-266.8%	$7.8M+174.6%	-$10.5M+53.2%	-$22.4M-142.0%	-$9.2M-310.5%	$4.4M-12.1%	$5.0M+76.0%	$2.8M+6.3%	$2.7M+825.1%	$288K-55.5%	$648K-35.9%	$1.0M
EPS (Basic)	N/A	-$210.88+21.7%	-$269.47+98.3%	-$15760.64-106175.4%	-$14.83-74250.0%	$0.02+102.0%	-$1.00+83.5%	-$6.07-574.4%	-$0.90-381.3%	$0.32-45.8%	$0.59+43.9%	$0.41+5.1%	$0.39+3800.0%	$0.01	N/A	$0.02
EPS (Diluted)	—	-$210.88	-$269.47	-$15760.64	-$14.83	$0.02	-$1.00	-$6.07	-$0.90-390.3%	$0.31	$0.59+47.5%	$0.40	$0.39	$0.01-50.0%	$0.02	$0.02
Diluted Shares (Avg)	N/A	132,396	27,240	414	709,488	19M	10M	2M	1M-86.2%	10M	9M+23.2%	7M	7M	41M	N/A	40M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$18.4M+8.7%	$18.1M-33.7%	$16.1M+17.4%	$18.5M+2.2%	$17.0M+15.5%	$27.3M+58.8%	$13.7M-18.6%	$18.1M+9.3%
Cost of Revenue	$10.7M+12.0%	$11.2M-25.7%	$10.5M+30.8%	$11.5M+8.7%	$9.6M+8.9%	$15.1M+47.6%	$8.0M-17.9%	$10.6M+8.1%
Gross Profit	$7.7M+4.4%	$6.8M-43.7%	$5.6M-1.4%	$7.1M-7.0%	$7.4M+25.4%	$12.2M+75.3%	$5.7M-19.5%	$7.6M+11.1%
R&D Expenses	$425K+10.0%	$547K-29.7%	$501K-43.7%	$299K-56.9%	$387K-55.3%	$778K-18.2%	$890K+4.9%	$693K-25.9%
SG&A Expenses	$7.9M+7.8%	$8.0M+23.2%	$7.6M+12.5%	$7.7M+19.7%	$7.3M-7.0%	$6.5M-3.8%	$6.8M+2.3%	$6.4M-17.3%
Operating Income	-$1.2M-85.7%	-$2.2M-147.0%	-$2.8M-23.0%	-$1.2M-270.1%	-$642K+79.8%	$4.6M+547.3%	-$2.3M-209.0%	-$320K-1608.0%
EBITDA	-$611K-85.6%	-$1.7M-133.6%	-$2.4M-23.1%	-$788K-7689.5%	-$329K+88.5%	$4.9M+777.5%	-$1.9M-425.4%	$10K-41.0%
Interest Expense	$470K+1.9%	$562K+24.1%	$12.1M+2405.3%	$712K+51.0%	$462K-11.5%	$453K-23.6%	$484K-17.1%	$472K-62.2%
Income Tax	-$119K-947.9%	$74K-33.2%	$266K+120.9%	$490K+1469.3%	$14K-79.1%	$111K+10.5%	$121K+70.4%	-$36K
Net Income	-$4.5M+3.3%	$907K-89.5%	-$20.6M+28.5%	-$3.4M-175.8%	-$4.6M+48.4%	$8.6M+686.3%	-$28.8M-2281.3%	$4.4M-31.9%
EPS (Basic)	-$3.27+37.2%	$0.12-99.8%	-$7.91+97.9%	-$199.20-110.1%	-$5.21-760.4%	$72.19+102.4%	-$383.87-15627.2%	$1963.45+112.5%
EPS (Diluted)	-$3.27	$0.11	-$7.91	-$199.20	-$5.21	$19.51	-$383.87	$1963.45+112.5%
Diluted Shares (Avg)	1M	10M	3M	N/A	890,432	440,146	74,210	N/A

CETXP Balance Sheet

CETXP quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$47.8M+8.3%	$44.1M-9.0%	$48.5M+5.9%	$45.8M-13.6%	$52.9M-13.0%	$60.8M+37.0%	$44.4M-32.0%	$65.3M-7.0%	$70.2M+25.2%	$56.0M+148.5%	$22.5M+13.6%	$19.8M+590.5%	$2.9M+71.2%	$1.7M-30.9%	$2.4M
Current Assets	$29.0M+8.7%	$26.7M-8.9%	$29.3M-7.8%	$31.8M-8.6%	$34.7M-4.0%	$36.2M+91.8%	$18.9M-40.8%	$31.9M-31.3%	$46.4M+25.7%	$36.9M+173.1%	$13.5M+17.1%	$11.5M+360.7%	$2.5M+59.5%	$1.6M-34.1%	$2.4M
Cash & Equivalents	$5.0M+27.6%	$3.9M-26.9%	$5.3M-46.1%	$9.9M-35.9%	$15.4M-20.8%	$19.5M+1001.0%	$1.8M+81.8%	$974K-90.7%	$10.4M+72.7%	$6.0M+306.6%	$1.5M+917.7%	$146K+118.2%	$67K-79.9%	$333K-19.8%	$415K
Short-Term Investments	$0	$0-100.0%	$14K-0.4%	$14K-8.4%	$15K-98.3%	$888K+115.1%	$413K	$0	$0	$0	$0-100.0%	$560K	$0	$0	$0
Inventory	$6.6M-5.8%	$7.0M-20.0%	$8.7M+3.0%	$8.5M+50.0%	$5.7M+14.4%	$4.9M-5.0%	$5.2M-54.1%	$11.4M-34.3%	$17.3M+22.7%	$14.1M+120.9%	$6.4M+1.6%	$6.3M+3835.0%	$159K-19.0%	$197K-38.1%	$318K
Accounts Receivable	$13.1M+17.7%	$11.2M+21.2%	$9.2M+70.6%	$5.4M-30.9%	$7.8M+16.8%	$6.7M+3.5%	$6.5M-53.7%	$13.9M-9.8%	$15.5M+13.9%	$13.6M+184.4%	$4.8M+18.1%	$4.0M+529.7%	$641K+118.7%	$293K+12.1%	$262K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$80K	$0
Goodwill	$3.7M0.0%	$3.7M-15.4%	$4.4M+12.2%	$3.9M-50.0%	$7.8M+8.3%	$7.2M+65.2%	$4.4M+31.5%	$3.3M0.0%	$3.3M+261.6%	$919K+8.7%	$845K0.0%	$845K	$0	N/A	N/A
Total Liabilities	$39.1M-0.2%	$39.2M-2.4%	$40.1M+28.9%	$31.1M+5.9%	$29.4M-8.1%	$32.0M+42.6%	$22.4M-25.2%	$30.0M-3.8%	$31.2M-22.7%	$40.3M+161.6%	$15.4M-4.8%	$16.2M+829.6%	$1.7M+108.5%	$836K-64.2%	$2.3M
Current Liabilities	$23.8M+28.1%	$18.6M-32.0%	$27.3M+7.2%	$25.5M+29.8%	$19.7M+20.6%	$16.3M+4.2%	$15.6M-28.6%	$21.9M+9.2%	$20.1M-20.2%	$25.2M+185.0%	$8.8M+40.8%	$6.3M+887.1%	$635K+76.8%	$359K-55.9%	$814K
Non-Current Liabilities	$15.2M-25.8%	$20.6M+61.1%	$12.8M+127.7%	$5.6M-42.4%	$9.7M-38.0%	$15.7M+131.1%	$6.8M-16.1%	$8.1M-27.2%	$11.1M-26.3%	$15.1M+129.0%	$6.6M-33.6%	$9.9M+796.6%	$1.1M+132.4%	$476K-68.7%	$1.5M
Long-Term Debt	$4.6M-65.4%	$13.3M+33.6%	$9.9M+319.4%	$2.4M-85.6%	$16.4M-15.5%	$19.4M+96560.8%	$20K-99.8%	$9.9M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$8.7M+85.1%	$4.7M-38.7%	$7.7M-44.9%	$13.9M-38.3%	$22.6M-18.8%	$27.8M+59.1%	$17.5M-50.5%	$35.3M-9.5%	$39.0M+158.4%	$15.1M+111.7%	$7.1M+95.6%	$3.6M+222.1%	$1.1M+34.2%	$843K+791.9%	$94K
Retained Earnings	-$99.4M-39.3%	-$71.4M-11.3%	-$64.1M-16.7%	-$54.9M-31.1%	-$41.9M-22.9%	-$34.1M-44.3%	-$23.6M-654.3%	$4.3M-70.4%	$14.4M+26.2%	$11.4M+77.7%	$6.4M+79.0%	$3.6M+288.9%	$924K+45.4%	$635K+5047.1%	-$13K

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$70.0M+49.1%	$70.7M+53.0%	$60.3M+29.2%	$47.8M+8.3%	$47.0M+7.2%	$46.2M-2.1%	$46.7M+3.1%	$44.1M-9.0%
Current Assets	$37.5M+27.9%	$37.9M+32.6%	$42.7M+47.1%	$29.0M+8.7%	$29.3M+11.0%	$28.6M+0.7%	$29.0M+10.0%	$26.7M-8.9%
Cash & Equivalents	$8.0M+13.4%	$6.6M+44.7%	$20.5M+385.4%	$5.0M+27.6%	$7.0M+8.7%	$4.5M+55.6%	$4.2M+49.0%	$3.9M-26.9%
Short-Term Investments	$3.7M	$5.0M	$0	$0	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%
Inventory	$8.0M+37.9%	$6.7M+9.8%	$7.4M-33.1%	$6.6M-5.8%	$5.8M-22.6%	$6.1M-17.0%	$11.1M+40.0%	$7.0M-20.0%
Accounts Receivable	$12.5M-1.3%	$13.3M+4.8%	$9.7M+5.4%	$13.1M+17.7%	$12.7M+62.5%	$12.7M+10.2%	$9.2M-7.1%	$11.2M+21.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$7.7M+107.3%	$7.7M+107.3%	$3.7M0.0%	$3.7M0.0%	$3.7M-12.5%	$3.7M-15.4%	$3.7M-15.4%	$3.7M-15.4%
Total Liabilities	$38.0M-11.8%	$36.0M-8.8%	$31.2M-35.2%	$39.1M-0.2%	$43.1M-0.8%	$39.5M-6.1%	$48.2M+26.8%	$39.2M-2.4%
Current Liabilities	$24.3M-0.2%	$24.2M+2.8%	$18.0M-27.9%	$23.8M+28.1%	$24.4M+74.2%	$23.6M+30.2%	$24.9M-13.2%	$18.6M-32.0%
Non-Current Liabilities	$13.7M-27.0%	$11.8M-25.9%	$13.3M-42.9%	$15.2M-25.8%	$18.7M-36.5%	$15.9M-33.6%	$23.3M+150.5%	$20.6M+61.1%
Long-Term Debt	$8.6M+1.2%	$8.8M-7.8%	$8.0M-32.4%	$4.6M-65.4%	$8.5M-49.8%	$9.5M-56.0%	$11.9M	$13.3M+33.6%
Total Equity	$32.0M+730.7%	$34.7M+415.9%	$29.1M+1965.3%	$8.7M+85.1%	$3.9M+7932.4%	$6.7M+43.5%	-$1.6M-123.1%	$4.7M-38.7%
Retained Earnings	-$123.5M-28.3%	-$119.0M-29.8%	-$120.0M-19.8%	-$99.4M-39.3%	-$96.3M-27.0%	-$91.7M-37.3%	-$100.1M-53.2%	-$71.4M-11.3%

CETXP Cash Flow Statement

CETXP quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$8.2M	$159K+104.0%	-$3.9M-76.9%	-$2.2M+86.1%	-$16.1M-60.1%	-$10.1M-165.5%	-$3.8M-196.2%	$3.9M+258.6%	-$2.5M-349.3%	$995K-87.4%	$7.9M+103.5%	$3.9M+265.6%	-$2.3M-276.0%	-$623K-166.2%	$941K+1027.3%	-$102K
Depreciation & Amortization	N/A	$1.4M+2.0%	$1.3M+29.5%	$1.0M-41.4%	$1.8M+31.2%	$1.3M-28.4%	$1.9M-38.1%	$3.0M+29.9%	$2.3M-26.2%	$3.1M+36.8%	$2.3M+197.2%	$772K+56.2%	$495K+4339.1%	$11K-40.9%	$19K-17.8%	$23K
Stock-Based Compensation	N/A	$14K-52.9%	$30K-71.7%	$107K-31.3%	$156K-0.6%	$156K-18.3%	$191K-69.2%	$622K+52.5%	$408K+504.4%	$68K+30.1%	$52K-9.4%	$57K	$0	N/A	$0	$0
Capital Expenditures	$1.5M	$1.9M+48.9%	$1.3M-53.0%	$2.8M+55.7%	$1.8M+65.9%	$1.1M	N/A	$1.7M-86.4%	$12.2M+115.0%	$5.7M+755.3%	$664K-56.2%	$1.5M-43.8%	$2.7M	N/A	N/A	N/A
Free Cash Flow	-$9.6M	-$1.8M+66.2%	-$5.2M-5.1%	-$5.0M+72.0%	-$17.9M-60.7%	-$11.1M	N/A	$2.3M+115.5%	-$14.7M-213.7%	-$4.7M-164.7%	$7.2M+205.9%	$2.4M+146.9%	-$5.0M	N/A	N/A	N/A
Investing Cash Flow	-$14.8M	-$3.0M-135.5%	-$1.3M+77.7%	-$5.6M-185.1%	$6.6M+686.1%	$841K+134.6%	-$2.4M-135.6%	$6.8M+156.0%	-$12.2M-115.0%	-$5.7M+66.9%	-$17.1M-1693.5%	-$956K	N/A	N/A	-$82K	$0
Financing Cash Flow	$24.1M	$4.1M-7.4%	$4.4M+116.0%	$2.0M-59.4%	$5.0M+13.0%	$4.4M-81.8%	$24.4M+305.9%	-$11.9M-321.6%	$5.4M-46.0%	$9.9M-28.2%	$13.8M+972.3%	-$1.6M	N/A	$357K+134.9%	-$1.0M-315.2%	$476K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$529K	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$410K-77.3%	-$4.4M-257.7%	-$892K+25.8%	-$3.3M-73.6%	$1.8M+167.9%	$2.8M+624.4%	-$1.2M+61.7%	-$1.9M-372.8%
Depreciation & Amortization	$582K+85.9%	$516K+66.2%	$412K+22.3%	$395K+19.5%	$313K-3.9%	$310K+1.8%	$337K-8.4%	$330K+0.7%
Stock-Based Compensation	N/A	N/A	$0-100.0%	N/A	$3K-59.0%	$3K-59.0%	$4K-45.9%	N/A
Capital Expenditures	$630K+731.4%	$153K-64.8%	$184K-80.1%	$496K-42.9%	$76K+2.4%	$436K+573.8%	$924K+218.0%	$868K-56.6%
Free Cash Flow	-$220K-112.7%	-$4.6M-293.2%	-$1.1M+49.4%	-$3.7M-36.7%	$1.7M+188.2%	$2.4M+634.6%	-$2.1M+38.0%	-$2.7M-108.7%
Investing Cash Flow	$694K+1615.7%	-$13.7M-3108.8%	-$253K+74.9%	-$1.5M-73.7%	-$46K-193.3%	-$428K-557.8%	-$1.0M-158.5%	-$851K+82.6%
Financing Cash Flow	$280K+227.4%	$3.6M+363.2%	$17.3M+624.8%	$3.0M+456.9%	$86K-96.7%	-$1.4M-636.8%	$2.4M+139.2%	$531K-84.0%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

CETXP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CETXP quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	42.2%+1.1pp	41.1%-2.2pp	43.3%+6.5pp	36.8%-2.6pp	39.3%-1.1pp	40.5%+0.9pp	39.6%+3.3pp	36.3%+3.2pp	33.1%+1.9pp	31.2%+2.5pp	28.7%-4.0pp	32.7%+24.4pp	8.4%-2.9pp	11.3%-4.2pp	15.5%
Operating Margin	0.7%+8.5pp	-7.9%-5.3pp	-2.5%+28.8pp	-31.4%-11.1pp	-20.3%-9.8pp	-10.5%+8.5pp	-19.0%+36.5pp	-55.4%-59.7pp	4.2%-1.2pp	5.4%+1.0pp	4.4%-1.9pp	6.3%+3.8pp	2.5%-3.2pp	5.7%-2.3pp	8.0%
Net Margin	-36.8%-25.9pp	-10.8%-8.3pp	-2.5%+26.4pp	-28.9%-47.0pp	18.1%+42.2pp	-24.1%+32.9pp	-57.0%-16.1pp	-40.8%-44.5pp	3.6%-1.7pp	5.3%+0.3pp	5.0%-0.6pp	5.6%+3.5pp	2.1%-3.2pp	5.3%-2.0pp	7.4%
Return on Equity	-322.5%-169.0pp	-153.5%-133.8pp	-19.7%+73.7pp	-93.4%-127.9pp	34.6%+72.2pp	-37.6%+90.3pp	-128.0%-101.8pp	-26.2%-37.5pp	11.3%-21.8pp	33.1%-6.7pp	39.8%-33.4pp	73.3%+47.8pp	25.5%-51.4pp	76.9%-993.0pp	1069.9%
Return on Assets	-58.8%-42.4pp	-16.4%-13.3pp	-3.1%+25.3pp	-28.5%-43.2pp	14.8%+32.0pp	-17.2%+33.2pp	-50.4%-36.2pp	-14.2%-20.4pp	6.3%-2.6pp	8.9%-3.7pp	12.6%-0.9pp	13.5%+3.4pp	10.0%-28.6pp	38.6%-3.0pp	41.6%
Current Ratio	1.22-0.2x	1.44+0.4x	1.07-0.2x	1.25-0.5x	1.77-0.5x	2.22+1.0x	1.21-0.2x	1.46-0.9x	2.31+0.8x	1.47-0.1x	1.53-0.3x	1.84-2.1x	3.95-0.4x	4.38+1.4x	2.93
Debt-to-Equity	0.53-2.3x	2.82+1.5x	1.29+1.1x	0.17-0.6x	0.730.0x	0.70+0.7x	0.00-0.3x	0.28-0.5x	0.80-1.9x	2.67+0.5x	2.16-2.3x	4.45+2.9x	1.54+0.5x	0.99-23.7x	24.71
Asset Turnover	1.60+0.1x	1.52+0.3x	1.23+0.2x	0.98+0.2x	0.81+0.1x	0.72-0.2x	0.88+0.5x	0.35-1.4x	1.720.0x	1.67-0.9x	2.52+0.1x	2.40-2.4x	4.76-2.5x	7.25+1.6x	5.65
FCF Margin	-2.3%+5.5pp	-7.8%+0.6pp	-8.4%+31.3pp	-39.7%-13.9pp	-25.8%	N/A	5.8%+70.7pp	-64.9%-61.0pp	-3.9%-11.6pp	7.7%+3.6pp	4.2%+14.7pp	-10.6%	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	41.7%-1.7pp	37.9%-6.7pp	34.8%-6.7pp	38.0%-3.7pp	43.4%+3.4pp	44.6%+4.2pp	41.5%-0.5pp	41.8%+0.7pp
Operating Margin	-6.5%-2.7pp	-12.0%-29.0pp	-17.4%-0.8pp	-6.4%-4.6pp	-3.8%+17.9pp	16.9%+22.9pp	-16.6%-12.2pp	-1.8%-1.7pp
Net Margin	-24.3%+3.0pp	5.0%-26.7pp	-127.4%	-18.1%-42.6pp	-27.3%+33.8pp	31.7%+40.3pp	-209.3%	24.4%-14.8pp
Return on Equity	-14.0%+106.3pp	2.6%-125.8pp	-70.7%	-38.6%-132.7pp	-120.3%+18607.3pp	128.4%+159.8pp	N/A	94.1%+9.4pp
Return on Assets	-6.4%+3.5pp	1.3%-17.4pp	-34.1%+27.5pp	-7.0%-17.1pp	-9.9%+10.6pp	18.7%+21.8pp	-61.6%-58.9pp	10.1%-3.4pp
Current Ratio	1.54+0.3x	1.57+0.4x	2.38+1.2x	1.22-0.2x	1.20-0.7x	1.21-0.4x	1.17+0.2x	1.44+0.4x
Debt-to-Equity	0.27-1.9x	0.25-1.2x	0.28	0.53-2.3x	2.20-350.1x	1.41-3.2x	N/A	2.82+1.5x
Asset Turnover	0.26-0.1x	0.26-0.3x	0.270.0x	0.390.0x	0.360.0x	0.59+0.2x	0.29-0.1x	0.41+0.1x
FCF Margin	-1.2%-11.4pp	-25.3%-34.0pp	-6.7%+8.8pp	-20.2%-5.1pp	10.2%+6.1pp	8.7%+6.8pp	-15.5%+4.8pp	-15.1%-7.2pp

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
CEMTREX INC SRS 1 PFD CETXP	FY2025	$76.5M	-$28.1M	-36.8%	N/A	—
GMTECH INC GMTH	FY2025	$3.5M	$413K	11.9%	$4K	—
ZAPATA QUANTUM INC ZPTA	FY2025	N/A	$9.3M	N/A	$1.2M	—
TOFLA MEGALINE INC TFLM	FY2024	$22K	-$25K	N/A	$1.0M	—

Where CEMTREX INC SRS 1 PFD Ranks

Frequently Asked Questions

What is CEMTREX INC SRS 1 PFD's annual revenue?

CEMTREX INC SRS 1 PFD (CETXP) reported $76.5M in total revenue for fiscal year 2025. This represents a 14.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CEMTREX INC SRS 1 PFD's revenue growing?

CEMTREX INC SRS 1 PFD (CETXP) revenue grew by 14.4% year-over-year, from $66.9M to $76.5M in fiscal year 2025.

Is CEMTREX INC SRS 1 PFD profitable?

No, CEMTREX INC SRS 1 PFD (CETXP) reported a net income of -$28.1M in fiscal year 2025, with a net profit margin of -36.8%.

What is CEMTREX INC SRS 1 PFD's EBITDA?

CEMTREX INC SRS 1 PFD (CETXP) had EBITDA of $1.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does CEMTREX INC SRS 1 PFD have?

As of fiscal year 2025, CEMTREX INC SRS 1 PFD (CETXP) had $5.0M in cash and equivalents against $4.6M in long-term debt.

What is CEMTREX INC SRS 1 PFD's gross margin?

CEMTREX INC SRS 1 PFD (CETXP) had a gross margin of 42.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is CEMTREX INC SRS 1 PFD's operating margin?

CEMTREX INC SRS 1 PFD (CETXP) had an operating margin of 0.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CEMTREX INC SRS 1 PFD's net profit margin?

CEMTREX INC SRS 1 PFD (CETXP) had a net profit margin of -36.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CEMTREX INC SRS 1 PFD's return on equity (ROE)?

CEMTREX INC SRS 1 PFD (CETXP) has a return on equity of -322.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CEMTREX INC SRS 1 PFD's free cash flow?

CEMTREX INC SRS 1 PFD (CETXP) recorded an outflow of $1.8M in free cash flow during fiscal year 2025. This represents a 66.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is CEMTREX INC SRS 1 PFD's operating cash flow?

CEMTREX INC SRS 1 PFD (CETXP) generated $159K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CEMTREX INC SRS 1 PFD's total assets?

CEMTREX INC SRS 1 PFD (CETXP) had $47.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are CEMTREX INC SRS 1 PFD's capital expenditures?

CEMTREX INC SRS 1 PFD (CETXP) invested $1.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does CEMTREX INC SRS 1 PFD spend on research and development?

CEMTREX INC SRS 1 PFD (CETXP) invested $2.4M in research and development during fiscal year 2025.

How many shares does CEMTREX INC SRS 1 PFD have outstanding?

CEMTREX INC SRS 1 PFD (CETXP) had 7M shares outstanding as of fiscal year 2025.

What is CEMTREX INC SRS 1 PFD's current ratio?

CEMTREX INC SRS 1 PFD (CETXP) had a current ratio of 1.22 as of fiscal year 2025, which is considered adequate.

What is CEMTREX INC SRS 1 PFD's debt-to-equity ratio?

CEMTREX INC SRS 1 PFD (CETXP) had a debt-to-equity ratio of 0.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CEMTREX INC SRS 1 PFD's return on assets (ROA)?

CEMTREX INC SRS 1 PFD (CETXP) had a return on assets of -58.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CEMTREX INC SRS 1 PFD's Piotroski F-Score?

CEMTREX INC SRS 1 PFD (CETXP) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CEMTREX INC SRS 1 PFD's earnings high quality?

CEMTREX INC SRS 1 PFD (CETXP) reported a net loss of $28.1M while generating $159K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CEMTREX INC SRS 1 PFD cover its interest payments?

CEMTREX INC SRS 1 PFD (CETXP) has an interest coverage ratio of 0.24x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.